These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5340822)

  • 21. Comparison of the therapeutic results of clothiapin and perphenazine in schizophrenia.
    Rodová A; Náhunek K; Svestka J
    Act Nerv Super (Praha); 1971; 13(3):171-3. PubMed ID: 4939829
    [No Abstract]   [Full Text] [Related]  

  • 22. Cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid in huntington's chorea.
    Mattsson B; Persson SA
    Acta Psychiatr Scand Suppl; 1974; 255():245-59. PubMed ID: 4282556
    [No Abstract]   [Full Text] [Related]  

  • 23. [USE OF REACTIONS TO PSYCHOPHARMACOLOGICAL AGENTS IN THE URINE IN PSYCHIATRIC PRACTICE].
    LAURENTOVA J; BASTECKY J; ECKERTOVA J; ZAPLATILKOVA H
    Act Nerv Super (Praha); 1963 May; 5():195-7. PubMed ID: 14073986
    [No Abstract]   [Full Text] [Related]  

  • 24. Chlorpromazine and the untreated chronic schizophrenic: a long-term trial.
    Letemendia FJ; Harris AD
    Br J Psychiatry; 1967 Sep; 113(502):950-8. PubMed ID: 4862704
    [No Abstract]   [Full Text] [Related]  

  • 25. PHENOTHIAZINE DERIVATIVES ON AVOIDANCE BEHAVIOR IN RATS.
    TANEMURA I; ITO S
    Tohoku J Exp Med; 1965 Feb; 85():83-8. PubMed ID: 14285070
    [No Abstract]   [Full Text] [Related]  

  • 26. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.
    Serafetinides EA; Willis D; Clark ML
    J Nerv Ment Dis; 1972 Nov; 155(5):366-9. PubMed ID: 4563078
    [No Abstract]   [Full Text] [Related]  

  • 27. [Gene localization might make it possible to prevent schizophrenia].
    Wetterberg L
    Lakartidningen; 1990 Jun; 87(23):2028-33. PubMed ID: 1972972
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical evaluation of pipotiazine palmitate (19.552 R.P.) used on patients in an acute reception ward.
    Elley JH; Petersen JH
    Acta Psychiatr Scand Suppl; 1973; 241():75-82. PubMed ID: 4147514
    [No Abstract]   [Full Text] [Related]  

  • 29. [Controlled comparative study of methylperidol and perphenazine in schizoprenic psychoses].
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1970 Jan; 12(1):57-8. PubMed ID: 4907391
    [No Abstract]   [Full Text] [Related]  

  • 30. Decreased concentration of high density lipoprotein cholesterol in schizophrenic patients treated with phenothiazines.
    Sasaki J; Kumagae G; Sata T; Kuramitsu M; Arakawa K
    Atherosclerosis; 1984; 51(2-3):163-9. PubMed ID: 6146320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1972; 14(2):93-4. PubMed ID: 4557145
    [No Abstract]   [Full Text] [Related]  

  • 32. Pilot trials with long-acting pipotiazine injections.
    Hakola A
    Acta Psychiatr Scand Suppl; 1973; 241():31-42. PubMed ID: 4147509
    [No Abstract]   [Full Text] [Related]  

  • 33. Specific indications for different classes of phenothiazines.
    Hollister LE; Overall JE; Kimbell I; Pokorny A
    Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and work performance variables in phenothiazine therapy of schizophrenia.
    Chacon C; Harper P
    Acta Psychiatr Scand; 1973; 49(1):65-76. PubMed ID: 4572169
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical evaluation of neuroleptic drug action, particularly considering butyrophenones.
    Kristjansen P
    Acta Psychiatr Scand Suppl; 1966; 191():171-7. PubMed ID: 5336724
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
    Keskiner A; Itil TM; Todt N
    Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
    [No Abstract]   [Full Text] [Related]  

  • 38. [Differential indication for the use of neuroleptics].
    Vinar O
    Act Nerv Super (Praha); 1970 Jan; 12(1):1-11. PubMed ID: 4907389
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of secondary depression in schizophrenia. A double-blind, placebo-controlled trial of amitriptyline added to perphenazine.
    Prusoff BA; Williams DH; Weissman MM; Astrachan BM
    Arch Gen Psychiatry; 1979 May; 36(5):569-75. PubMed ID: 373665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia.
    Morton MR
    Am J Psychiatry; 1968 May; 124(11):1585-8. PubMed ID: 4869439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.